Precision Biopsy, LLC logo — company profile

Precision Biopsy, LLC

Founded 2008 United States Aurora, United States 12 employees Series B Total: $36.10M Biotechnology, Health Care +1

General Information

Company Name Precision Biopsy, LLC
Founded Year 2008
Location United States Aurora, United States +1
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

Get notified when Precision Biopsy, LLC moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Precision Biopsy, LLC

Precision Biopsy, LLC was founded in 2008 in the United States in partnership with Allied Minds to develop innovative technology for precise prostate cancer diagnosis. The company's diagnostic approach integrates advanced spectroscopy imaging techniques with tissue biopsy to eliminate random and error-prone biopsies. This precision leads to more accurate grading and staging of the disease. The scientific founders, professors Priya Werahara and John Daily from the University of Colorado, have extensive experience in cancer tissue morphology. Their expertise in advanced spectroscopy has enabled them to create a technique that precisely images the location of cancer in the prostate. In October 2015, Precision Biopsy, LLC received a significant $33.60M Series B investment from Woodford Patient Capital Trust and its parent company Allied Minds. As a subsidiary of Allied Minds, a pioneering U.S. science and technology development and commercialization company, Precision Biopsy, LLC is positioned for substantial growth and impact in the Biotechnology and Health Care industries. For more information about Allied Minds, visit www.alliedminds.com.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 2
Investor Investor
05 Oct 2015
Series A •••••• 1
Investor
08 Nov 2011

Precision Biopsy, LLC Alternatives & Competitors

Precision Biopsy, LLC vs

Precision Health. Accurate Results.

Grant
19 employees
Biotechnology, Health Care
Precision Biopsy, LLC vs
miR Scientific, LLC
miR Scientific, LLC United States

miR Scientific is a healthcare company that is committed to transforming cancer management globally.

14 employees
Biotechnology, Health Care
Precision Biopsy, LLC vs
Sensome
Sensome France

Sensitive Medical Devices

Series B
39 employees
Health Care, Medical Devices

FAQ About Precision Biopsy, LLC

Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with tissue biopsy. For the first time, this...
Precision Biopsy, LLC was founded in 2008.
Precision Biopsy, LLC is headquartered in Aurora, United States.
Precision Biopsy, LLC operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Precision Biopsy, LLC has approximately 12 employees.
Precision Biopsy, LLC has completed 2 funding rounds, raising a total of $36.10M. The latest funding stage is Series B.
Top alternatives and competitors to Precision Biopsy, LLC include Nanostics Inc., miR Scientific, LLC, Sensome, Wren Laboratories, KOELIS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Precision Biopsy, LLC and Nanostics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Precision Biopsy, LLC and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy